Skip to main content

Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring

Project description

Tumour chip technology to mimic how cancer cells react to drugs

Selecting the most effective therapy for each cancer patient is the Holy Grail in cancer treatment. The low efficacy of many cancer treatments mostly arises from the limited ability to predict the patient tumour response to therapeutic agents. The EU-funded BITFORM project is developing an engineered system that should allow accurate tumour response prediction to anti-cancer drugs and further improve patients’ outcome. This will be a breast cancer ecosystem-on-a-chip bioreactor that will conserve the cancer tissue characteristics with high reliability. Breast cancer cell secreted biomarkers will be monitored in real time by a connected biosensing module. The new platform is expected to lead to a new methodology for effectively testing anti-cancer therapies on a chip.

Coordinator

UNIVERSIDAD POLITECNICA DE MADRID
Net EU contribution
€ 245 732,16
Address
Calle Ramiro De Maeztu 7 Edificio Rectorado
28040 Madrid
Spain

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Partners (2)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Participation ended

United States
Net EU contribution
€ 0,00
Address
Franklin Street 1111 12 Floor
94607 Oakland Ca

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 61 974,72
Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION
United States
Net EU contribution
€ 0,00
Non-EU contribution
€ 103 291,20